Nelson Michael Aaron 13D and 13G filings for Bellerophon Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-03-01 10:04 am Unchanged |
2024-02-22 | 13G | Bellerophon Therapeutics, Inc. BLPH |
Nelson Michael Aaron | 642,844 5.300% |
0 (Unchanged) |
Filing |
| 2024-01-26 2:31 pm Purchase |
2024-01-16 | 13G | Bellerophon Therapeutics, Inc. BLPH |
Nelson Michael Aaron | 642,844 5.300% |
642,844 (New Position) |
Filing |